Redeye retains its positive view on Formpipe following a solid Q2 report with strong ACV and positive signs in Public SE. We leave our forecasts and Base Case largely unchanged.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/